Menu
Skip to content
Home
About Us
Services
Products
Contact Us
News & Events
In development
Patented products available for R&D use as permitted under 35 USC 271 (e)(1)
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
A
Afatinib
Ansamitocin P-3
Axitinib
B
Besifloxacin
Brexpiprazole
Brivaracetam
D
Dalbavancin
Dapagliflozin
Degarelix acetate
E
Emodepside
Empagliflozin
Epothilone B
Eribulin Mesilate
Everolimus
F
Ferric Carboxymaltose
Fulvestrant
I
Iodixanol
Ivacaftor
Ixazomib
L
Lenalidomide
Lurasidone HCl
M
Memantine HCl
Midostaurin
Migalastat
N
Naquotinib
Neratinib
Niraparib
O
Oritavancin
P
Palbociclib
Paliperidone Palmitate
Parnaparin Sodium
Platensimycin
Pomalidomide
Q
Quinupristin
R
Radezolid
Ravuconazole
Regorafenib
Retigabine
Robenacoxib
Rucaparib
S
Simeprevir
Sofosbuvir
T
Tasimelteon
Tedizolid
Terlipressin acetate
Trabectedin
Tulathromycin
Tylosin
U
Upadacitinib
V
Valrubicin
Vilazodone HCl